Reconstituting 36 mg of Retatrutide to 4 mg/mL
To achieve a concentration of 4 mg/mL from 36 mg of retatrutide, add 9 mL of sterile diluent (bacteriostatic water or sterile water for injection) to the vial.
Calculation Method
The basic reconstitution formula is straightforward:
- Desired concentration = Total drug amount ÷ Total volume
- Required volume = Total drug amount ÷ Desired concentration
- 9 mL = 36 mg ÷ 4 mg/mL 1
This yields exactly 4 mg per milliliter in the final solution.
Reconstitution Procedure
Preparation Steps
- Use aseptic technique throughout the entire reconstitution process to prevent contamination and maintain sterility 1
- Gather all necessary supplies before beginning: the retatrutide vial, appropriate volume syringe (10 mL), sterile diluent, alcohol swabs, and proper labeling materials 1
- Allow the retatrutide vial and diluent to reach room temperature (approximately 30 minutes if refrigerated) before reconstitution to ensure proper mixing 1
Mixing Technique
- Draw up exactly 9 mL of sterile diluent using a sterile syringe, ensuring accurate measurement 1
- Inject the diluent slowly down the side of the vial rather than directly onto the powder to minimize foaming 1
- Gently swirl the vial in a circular motion until the powder is completely dissolved; do not shake vigorously as this can denature the peptide 1
- Inspect the solution visually to ensure it is clear and free of particulates before use 1
- Remove any air bubbles by holding the vial upright and gently tapping the side 1
Critical Labeling Requirements
Proper labeling is essential to prevent medication errors and ensure safe administration 1:
- Patient identification (name and medical record number)
- Medication name: "Retatrutide"
- Concentration: "4 mg/mL"
- Total volume: "9 mL"
- Total drug amount: "36 mg"
- Diluent used: specify type (e.g., "bacteriostatic water")
- Date and time of reconstitution
- Preparer's initials or identification
- Expiration date/time (based on stability data or manufacturer recommendations)
- Storage requirements (typically refrigerated 2-8°C) 1
Common Pitfalls to Avoid
- Do not use expired diluent or retatrutide, as this compromises both safety and efficacy 1
- Avoid vigorous shaking, which can cause protein aggregation and reduce drug potency 1
- Do not use if the solution appears cloudy, discolored, or contains particles after reconstitution 1
- Never mix retatrutide with other medications in the same vial 1
- Ensure accurate volume measurement; even small errors in the diluent volume will alter the final concentration significantly 1
Storage and Stability
- Store the reconstituted solution in the refrigerator at 2-8°C unless manufacturer guidelines specify otherwise 1
- Protect from light during storage to maintain stability 1
- Use within the timeframe specified by stability data (typically 28 days for peptide medications when using bacteriostatic water, but verify with product-specific information) 1
- Discard any unused portion after the expiration date/time indicated on the label 1
Verification Before Administration
- Double-check the concentration calculation before first use: 4 mg/mL means each 1 mL contains 4 mg of retatrutide 1
- Confirm the dose prescribed matches what can be accurately drawn from this concentration 1
- Verify the route of administration is subcutaneous, as retatrutide is administered subcutaneously once weekly 2, 3